Fennec Pharmaceuticals Inc. (FENC)
NASDAQ · Healthcare
Fennec Pharmaceuticals Inc. Shareholder Equity 2011–2025
Fennec Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Fennec Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were 35.5M, a 704.09% decrease year-over-year.
- Fennec Pharmaceuticals Inc. shareholder equity for 2025 were 35.5M, a 704.09% decrease from 2024.
- Fennec Pharmaceuticals Inc. shareholder equity for 2024 were -5.9M, a 49.48% decrease from 2023.
- Fennec Pharmaceuticals Inc. shareholder equity for 2023 were -11.6M, a 352.39% increase from 2022.
- Fennec Pharmaceuticals Inc. shareholder equity for 2022 were -2.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Fennec Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $35 |
| 2024 | $-6 |
| 2023 | $-12 |
| 2022 | $-3 |
| 2020 | $29 |
| 2019 | $12 |
| 2018 | $21 |
| 2017 | $27 |
| 2016 | $4 |
| 2015 | $1 |
| 2014 | $1 |
| 2013 | $-1 |
| 2012 | $-5 |
| 2011 | $-0 |
| Fennec Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $35 |
| 2024-12-31 | $-6 |
| 2023-12-31 | $-12 |
| 2022-12-31 | $-3 |
| 2020-12-31 | $29 |
| 2019-12-31 | $12 |
| 2018-12-31 | $21 |
| 2017-12-31 | $27 |
| 2016-12-31 | $4 |
| 2015-12-31 | $1 |
| 2014-12-31 | $1 |
| 2013-12-31 | $-1 |
| 2012-12-31 | $-5 |
| 2011-12-31 | $-0 |
Fennec Pharmaceuticals Inc. Shareholder Equity — FAQ
Fennec Pharmaceuticals Inc. (FENC) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FENC's shareholder equity history?
The chart and table above show Fennec Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.